Quantcast

Latest Cell Genesys Stories

2010-09-22 05:00:00

Randomized Phase 2 Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer. Chi K.N., et al. JCO Sep 20, 2010: 4247-4254 BOTHELL, WA and VANCOUVER, Sept. 22 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc.

2009-10-21 08:30:00

TUSTIN, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.

2009-09-10 07:46:00

NEW YORK, Sept.

2009-02-25 07:00:00

- New Progression-Free Survival Data Support Picoplatin in Combination with Docetaxel/Prednisone as First-Line Therapy for Metastatic Castration-Resistant Prostate Cancer - - Results To Be Presented at the American Society of Clinical Oncology's 2009 Genitourinary Cancers Symposium - SOUTH SAN FRANCISCO, Calif., Feb.

2008-11-06 18:00:22

Cell Genesys, Inc. (Nasdaq:CEGE) today reported financial results for the third quarter ended September 30, 2008.

2008-10-22 06:00:08

SOUTH SAN FRANCISCO, Calif. and GENEVA, Oct. 22 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc.

2008-10-20 09:00:41

Cell Genesys, a biotechnology company, has terminated the Vital-1 Phase III clinical trial of Gvax immunotherapy in patients with asymptomatic metastatic hormone-refractory prostate cancer.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related